27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
- Vision-enhancement platform eSight has entered into a strategic partnership with Gentex Corp (NASDAQ:GNTX) to create assistive wearable technology for those with degenerative eyes diseases causing visual impairment. The financial terms were not disclosed.
- eSight uses a combination of hardware and software to enhance vision through a wearable device.
- eSight noted Gentex's capacity and design quality would enable mass-scale production for the next eSight device.
- "While medical scientists research the cause for hundreds of degenerative eye conditions, we're working with eSight to create assistive technology that helps those losing their sight be able to maintain their current lifestyle," said Gentex Chief Technology Officer Neil Boehm.
- Price Action: GNTX shares are trading higher by 0.57% at $35.05 on the last check Monday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!